Mark Goodman Mark Goodman is a professor in the Department of Radiology and the director of the Radiopharmaceutical Discovery Lab. His research centers on the radiotracer development of positron emission tomography(PET) and single photon emission computed tomography(SPECT). Additionally, his research helps the development of a commercialized radiotracer, methylbranched fatty acid [123I] BMIPP (Cardiodine), in Japan.   https://winshipcancer.emory.edu/bios/faculty/goodman-mark-m.html   Technologies PET Imaging Agents for Tumor Detection CRF-1 Receptor Antagonists for PET Imaging or as Potential Therapeutics Amino Acid-Derived Radiotracer Compounds for PET Cancer Imaging Precursor PET Compound for Imaging Infections CXCR4-Targeting Molecules for Tumor Metastasis and PET Imaging

Categories Diagnostics Drug Discovery Medical Medical Device Micro and Nanotechnology Non-Therapeutics Research Tools Software TechPub Algolia > Diagnostics TechPub Algolia > Drug Discovery TechPub Algolia > Medical Device TechPub Algolia > Micro and Nanotechnology TechPub Algolia > Non-Therapeutics TechPub Algolia > Research Tools TechPub Algolia > Software TechPub Algolia > Therapeutics TechPub Algolia > Vaccines Therapeutics Vaccines